Current Report Filing (8-k)
November 30 2016 - 4:24PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report: November 30, 2016
(Date of earliest event reported)
Imperva, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other
Jurisdiction
of Incorporation)
|
|
|
|
|
001-35338
|
|
03-0460133
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
3400 Bridge Parkway
Redwood Shores, California
|
|
94065
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
(650)
345-9000
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instructions A.2. below):
|
☐
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
|
☐
|
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
|
☐
|
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule; Transfer of Listing.
On November 30, 2016, Imperva, Inc. (“Imperva”) provided written notice to the New York Stock Exchange (“NYSE”) that Imperva
expects to voluntarily delist from the NYSE at the close of trading on December 12, 2016, and intends to transfer its listing to the NASDAQ Global Select Market (“NASDAQ”) to commence trading on the next business day,
December 13, 2016. Imperva’s common stock has been approved for listing on NASDAQ, and will continue to trade under the stock symbol “IMPV.”
A copy of the press release issued by Imperva to announce this change is furnished as Exhibit 99.1 to this report.
Item 9.01. Financial Statements and Exhibits.
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
99.1
|
|
Press release issued by Imperva, Inc., dated November 30, 2016.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
IMPERVA, INC.
|
|
|
|
|
|
|
Date: November 30, 2016
|
|
|
|
By:
|
|
/s/ Terrence J. Schmid
|
|
|
|
|
|
|
|
Terrence J. Schmid
|
|
|
|
|
|
|
|
Chief Financial Officer
|
EXHIBIT INDEX
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
99.1
|
|
Press release issued by Imperva, Inc., dated November 30, 2016.
|
Imperva, Inc. (NASDAQ:IMPV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Imperva, Inc. (NASDAQ:IMPV)
Historical Stock Chart
From Apr 2023 to Apr 2024
